WATERTOWN, Mass.--(BUSINESS WIRE)--July 11, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC - News), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Graham P. Allaway, Ph.D., previously Chief Operating Officer of Panacos, has been promoted to the position of President and Chief Operating Officer. In this role, Dr. Allaway is responsible for Panacos’ drug discovery and development programs, and plays a key role in corporate strategy, business development, and investor relations.
